Results 21 to 30 of about 2,642 (189)

Carcinoma hepatocelular. Parte 1: considerações gerais e diagnóstico [PDF]

open access: yesArquivos de Gastroenterologia, 2000
São revistos aspectos relativos à incidência/prevalência, fatores de risco, proliferação celular (carcinogênese), anatomia patológica, progressão e evolução das hepatites virais B e C para o carcinoma hepatocelular inicial, alguns dados clínicos da ...
Vinício Paride CONTE
doaj   +1 more source

Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics

open access: yesAdvanced Healthcare Materials, Volume 10, Issue 16, August 18, 2021., 2021
Selenium has anti‐inflammatory, immunomodulatory and antioxidant properties, and its application in nanotechnology improves its therapeutic properties, while decreasing the potential toxicity. Selenium nanoparticles have medicinal applications against diabetes, Alzheimer's disease, inflammatory and autoimmune diseases, microbial infections, and several
Cláudio Ferro   +2 more
wiley   +1 more source

Seminário Carcinoma Hepatocelular

open access: yes, 2021
Apresentação pessoal sobre Carcinoma Hepatocelular para o Módulo de Prática Médica V do curso de medicina da Universidade de ...
Letícia Nunes Campos
core   +2 more sources

Carcinoma hepatocelular. Diagnóstico diferencial

open access: yesRECIAMUC, 2021
El carcinoma hepatocelular o hepatocarcinoma es la neoplasia primaria hepática maligna más común a nivel mundial. Por lo general se desarrolla en pacientes con enfermedad hepática crónica que han desarrollado una cirrosis de cualquier etiología, más es particularmente asociada con a con infección por los virus de la hepatitis B y C (VHB y VHC).
Karla Abigail Navarrete Bolaños   +3 more
openaire   +4 more sources

Volume–outcome relationship of liver surgery: a nationwide analysis

open access: yesBJS (British Journal of Surgery), Volume 107, Issue 7, Page 917-926, June 2020., 2020
This study analysed the association between hospital volume and postoperative outcomes in the nationwide Dutch Hepato Biliary Audit. A total of 5590 resections was performed across 34 centres with a median annual centre volume of 35 (i.q.r. 20–69) procedures. No association was found between hospital and postoperative outcomes.
P. B. Olthof   +36 more
wiley   +1 more source

Liver resection with thrombectomy for patients with hepatocellular carcinoma and tumour thrombus in the inferior vena cava or right atrium

open access: yesBJS Open, Volume 4, Issue 2, Page 241-251, April 2020., 2020
Hepatocellular carcinoma with tumour thrombus in the inferior vena cava or right atrium is an advanced disease state with a poor prognosis. This retrospective study examined the survival benefits of surgical resection for patients with this rare condition.
S. Matsukuma   +9 more
wiley   +1 more source

Rotura espontánea como forma de presentación de carcinoma hepatocelular no conocido: a propósito de un caso

open access: yesRevista Chilena de Radiología, 2022
El carcinoma hepatocelular es la sexta neoplasia más frecuente en el mundo y la tercera causa de muerte en pacientes oncológicos. La mortalidad en los pacientes con esta condición se debe fundamentalmente a la caquexia tumoral, la insuficiencia hepática ...
Fernando L. Begliardo   +3 more
doaj   +1 more source

Influence of socioeconomic status on immediate breast reconstruction rate, patient information and involvement in surgical decision‐making

open access: yesBJS Open, Volume 4, Issue 2, Page 232-240, April 2020., 2020
Socioeconomic factors independently influence immediate breast reconstruction rates in Sweden. Patient‐reported information and involvement in the surgical decision‐making process remain independent predictors of the likelihood of undergoing immediate breast reconstruction.
A. Frisell   +3 more
wiley   +1 more source

Upper Gastrointestinal Hemorrhage as an Unexpected Feature of Hepatocellular Carcinoma [PDF]

open access: yesGE: Portuguese Journal of Gastroenterology, 2015
Rosa Coelho   +6 more
doaj   +2 more sources

Treatment patterns and survival in patients with hepatocellular carcinoma in the Swedish national registry SweLiv

open access: yesBJS Open, Volume 4, Issue 1, Page 109-117, February 2020., 2020
Of 3376 patients diagnosed in contemporary clinical care with hepatocellular carcinoma in Sweden and registered in SweLiv between 1 January 2009 and 31 December 2016, 60 per cent were recommended to receive active treatment in a curative or palliative mode.
M. Henriksson   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy